Glaucoma Therapeutics Market Size and Forecasts (2023 - 2033), Segmentation and Regional Share, Trends, and Growth Opportunity Analysis

The global Cardiovascular Devices market was valued at USD 6.88 billion in 2022 and expected to grow at a CAGR of 5.6% during the forecast period.

Glaucoma is a group of eye conditions that damage the optic nerve, which is responsible for transmitting visual signals from the eye to the brain. Glaucoma can lead to vision loss or blindness if left untreated. Glaucoma therapeutics refer to medications and treatments used to manage or prevent the progression of glaucoma. The main objective of glaucoma therapeutics is to lower the intraocular pressure (IOP) within the eye, as high IOP is a major risk factor for glaucoma. The treatment options for glaucoma include eye drops, oral medications, laser therapy, and surgery.

Get the report with Full Information: - https://wemarketresearch.com/r....eports/glaucoma-ther